Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Zunera Turk
Treatment Against Mutation of PIK3CA Gene Involved in Lung Cancer by Structure Base Pharmacophore Modeling, Virtual Screening and Molecular Docking
Advances in Pharmacology and Pharmacy
Related publications
Identification of Novel Acetylcholinesterase Inhibitors Designed by Pharmacophore-Based Virtual Screening, Molecular Docking and Bioassay
Scientific Reports
Multidisciplinary
In Silico Studies on Novel Inhibitors of MERS-CoV: Structure-Based Pharmacophore Modeling, Database Screening and Molecular Docking
Tropical Journal of Pharmaceutical Research
Pharmacology
Pharmaceutical Science
Structure-Based Virtual Screening and Molecular Docking for the Identification of Potential Multi-Targeted Inhibitors Against Breast Cancer
Breast Cancer: Targets and Therapy
Oncology
Potent Bace-1 Inhibitor Design Using Pharmacophore Modeling, in Silico Screening and Molecular Docking Studies
BMC Bioinformatics
Biochemistry
Applied Mathematics
Computer Science Applications
Structural Biology
Molecular Biology
Identification of New Potential APE1 Inhibitors by Pharmacophore Modeling and Molecular Docking
Genomics and Informatics
Evolution
Ecology
Genetics
Systematics
Health Informatics
Behavior
Insight Into the Structure of Tetramer hTRPV1 From Homology Modeling, Molecular Docking, Molecular Dynamics Simulation and Virtual Screening
Biophysical Journal
Biophysics
Virtual Screening Using Structure-Based Consensus Pharmacophore Models and Ensemble Docking Based on MD-generated Conformations
Journal of Cheminformatics
Computer Graphics
Information Sciences
Library
Theoretical Chemistry
Computer Science Applications
Computer-Aided Design
Physical
PIK3CA and PTEN Gene and Exon Mutation-Specific Clinicopathologic and Molecular Associations in Colorectal Cancer
Clinical Cancer Research
Cancer Research
Oncology
A Combination of Pharmacophore Modeling, Molecular Docking and Virtual Screening Study Reveals 3,5,7-Trihydroxy-2-(3,4,5-Trihydroxyphenyl)- 4h-Chromen-4-One as a Potential Anti-Cancer Agent of COT Kinase
Indian Journal of Pharmaceutical Education and Research
Toxicology
Pharmaceutics
Pharmacology